Objective: To observe efficacy and side effects, as well as the impact on quality of life, of Kanglaite® (CoixSeed Oil) injections combined with chemotherapy in the treatment of advanced gastric cancer patients. Method:A consecutive cohort of 60 patients were divided into two groups: the experimental group receiving Kanglaite®Injection combined with chemotherapy and the control group with chemotherapy alone. After more than twocourses of treatment, efficacy, quality of life and side effects were evaluated. Results: The response rate andKPS score of experimental group were significantly improved as compared with those of the control group(P<0.05). In addition, gastrointestinal reactions and bone marrow suppression were significantly lower than inthe control group (P<0.05). Conclusions: Kanglaite® Injection enhanced efficacy and reduced the side effects ofchemotherapy, improving quality of life of gastric cancer patients; use of Kanglaite® injections deserves to befurther investigated in randomized control clinical trails.
(2012). Clinical Safety and Efficacy of Kanglaite® (Coix Seed Oil) Injection Combined with Chemotherapy in Treating Patients with Gastric Cancer. Asian Pacific Journal of Cancer Prevention, 13(10), 5319-5321.
MLA
. "Clinical Safety and Efficacy of Kanglaite® (Coix Seed Oil) Injection Combined with Chemotherapy in Treating Patients with Gastric Cancer". Asian Pacific Journal of Cancer Prevention, 13, 10, 2012, 5319-5321.
HARVARD
(2012). 'Clinical Safety and Efficacy of Kanglaite® (Coix Seed Oil) Injection Combined with Chemotherapy in Treating Patients with Gastric Cancer', Asian Pacific Journal of Cancer Prevention, 13(10), pp. 5319-5321.
VANCOUVER
Clinical Safety and Efficacy of Kanglaite® (Coix Seed Oil) Injection Combined with Chemotherapy in Treating Patients with Gastric Cancer. Asian Pacific Journal of Cancer Prevention, 2012; 13(10): 5319-5321.